Talk about bad blood. Health experts are sounding the alarm over a disturbing trend where drug users swap blood to score a ...
More than 40 years after the first AIDS cases, new long-acting drugs and antibody-based therapies are reviving hopes that HIV ...
The biopharma will aim to bolster its pipeline, with plans to present updated results for novel long-acting combination ...
Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced today the presentation of additional data ...
Merck's two-drug HIV regimen doravirine/islatravir maintained viral suppression and matched Gilead's Biktarvy in Phase 3 ...
Once HIV infects a cell, the virus inserts its genetic information into the DNA, making the infection generally incurable.
Stellantis tracks back Jeep production in Ontario after massive $13 billion U.S. investment plan What happened after Michael ...
The adult-specific 21-valent pneumococcal conjugate vaccine was well tolerated and immunogenic across all 21 serotypes in patients with HIV infection.
Researchers at Western and the University of Calgary have discovered how HIV hides in different parts of the body by ...
NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), reports that an analyst research report was published on the ...
Lenacapavir is not a vaccine. It’s a long-acting retroviral drug that prevents HIV infection by blocking the virus from replicating in the body, rather than stimulating the immune system like a ...